Deal of the Day — limited-time pharmacy picks!
Canrib 100mg Tablet

Canrib 100mg Tablet

Salt Composition: Olaparib

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

60 Tablets in Bottle

About The Product

Ovarian Cancer, Breast Cancer

Description

Canrib 100mg tablet is a prescription based medication. It is used in the treatment of ovarian and breast cancer in adult patients.

Its active ingredient is Olaparib and belongs to the class of PARP inhibitor. The medication works by targeting specific protein or pathways that help cancer cells grow.

Strict doctor prescription is needed as the medication is not recommended to adult child under the age of 18. Proper medical supervision is essential while taking the medication to monitor effectiveness and manage any potential side effects.

Indication

Breast and ovarian cancer

Common Side Effects

• Muscle cramps
• Confusion, visual disturbances, seizures, and headache
• Breathlessness
• Swelling of feet
• Changes in heartbeat
• High blood pressure
• Pneumonia
• Loss of appetite
• Sensitivity, tingling and burning sensation of the skin
• Nausea, vomiting, and diarrhea
• Mouth ulcers
• Constipation

Dosage And Duration

  • Canrib 100mg tablet should be taken orally with a whole glass.
  • The medication can be taken with or without food at the fixed time everyday, as directed by the healthcare professional.
  • Do not crush or chew the tablet as this can affect the way the medicine is absorbed and reduce its effectiveness.
  • Doctor Presrcription is still needed during the treatment as it should be used strictly under medical supervision.

Mechanism Of Action

Breast and ovarian cancer is caused by the mutation in DNA which turns healthy blood cells into abnormal cells. Canrib 100mg tablet contains PARP inhibitor which directly block the mutated gene and slow the progression of cancer cells in the body.

The tablet helps prevent the tumor from growing and spreading to other parts of the body. By inhibiting PARP enzyme, it also prevent cancer cells from repairing damaged DNA, leading to cancer cell death.

Safety Advice

Alcohol
Taking Canrib 100mg tablet with alcohol is may be dangerous to the patient health but consult the doctor before taking the medication.
Driving
Canrib 100mg tablet may not cause dizziness or sleepiness but patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.
Pregnancy
Canrib 100mg tablet is not recommended to pregnant and breastfeeding women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.
Breast Feeding
Breastfeeding women should not be advisable for taking Canrib 100mg tabletas the medicine is passed through breast that somehow affect breast milk. Discuss with the doctor for more query.
Kidney
Kidney patients should take precautions while using Canrib 100mg tablet as dose adjustment and doctor's prescription is much needed.

Faqs

Canrib 100mg tablet is taken by breast and ovarian cancer patients under the guidance of doctor prescription.

It should be taken exactly as prescribed at the same time each day.

References

• Gonzalez-Juarrero, M., Lukka, P. B., Wagh, S., Walz, A., Arab, J., Pearce, C., ... & Meibohm, B.

(2021). Preclinical evaluation of inhalational spectinamide-1599 therapy against tuberculosis.

ACS infectious diseases, 7(10), 2850-2863. • Nasrollah, L., & Kiafar, C. (2015).

An Unusual Case of Upper Gastrointestinal Bleeding: 542. Official journal of the American College of Gastroenterology| ACG, 110, S236-S237. • Ali, M.

Z., Dutt, T. S., MacNeill, A., Walz, A., Pearce, C., Lam, H., ... & Juarrero, M.

G. (2024).

A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides. Elife, 13, RP96190. • Belardinelli, J.

M., Verma, D., Li, W., Avanzi, C., Wiersma, C. J., Williams, J.

T., ... & Jackson, M. (2022).

Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus. Science translational medicine, 14(633), eabj3860. • Greenblatt, R.

B., Samaras, C., Vasquez, J. M., & Nezhat, C.

(1982). Fibrocystic disease of the breast.

Clinical Obstetrics and Gynecology, 25(2), 365-371.

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026